-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FSDgDb8L9cBHkHWamBjT2rCA3XWm2Yo7E0EWoBfmG3P+/xyloXte/T37IMupMuBv YqfXkX/CSYVRdie46fgtdA== 0000950120-08-000484.txt : 20080929 0000950120-08-000484.hdr.sgml : 20080929 20080929165900 ACCESSION NUMBER: 0000950120-08-000484 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080923 FILED AS OF DATE: 20080929 DATE AS OF CHANGE: 20080929 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geller Matthew CENTRAL INDEX KEY: 0001446201 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19879 FILM NUMBER: 081095072 BUSINESS ADDRESS: BUSINESS PHONE: (917)509-6062 MAIL ADDRESS: STREET 1: 248 CENTRAL PARK WEST CITY: NEW YORK STATE: NY ZIP: 10024 3 1 gellerform3_092908ex.xml X0203 3 2008-09-23 0 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC.OB 0001446201 Geller Matthew 248 CENTRAL PARK WEST NEW YORK NY 10024 1 0 0 0 Stock Option (Right to Buy) 19.00 2018-09-21 Common Stock, $.001 par value 15000 D Stock Option (Right to Buy) 19.00 2018-09-21 Common Stock, $.001 par value 15000 D On September 22, 2008, the Issuer granted to the Reporting Person two options, which each vest monthly with respect to 1/12 of the total number of shares until all shares underlying each of the options have vested. /s/ Matthew Geller 2008-09-29 -----END PRIVACY-ENHANCED MESSAGE-----